arrow
V

Vincent Probst

institut du thorax
H指数:74
被引数:2.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Ajmaline or flecainide testing in Brugada syndrome: influence of SCN5A variants

维拉帕米或氟卡尼测试在Brugada综合征中的应用:SCN5A变异的影响

2026-08-260
PRE
Early complications and long-term outcomes of patients treated with a subcutaneous cardioverter-defibrillator: temporal trends and clinical implications of the anaesthetic strategies adopted at implant

皮下植入型心律转复除颤器治疗患者的早期并发症和长期结局:植入时采用麻醉策略的时间趋势及临床意义

2026-06-120
OAAI
Ventricular conduction is a marker for arrhythmic risk in SCN5A-E1784K overlap sodium channel disease

室性传导是SCN5A-E1784K重叠钠通道疾病中心律失常风险的标志物

2026-05-110
OA
LB-525395-01 A RANDOMIZED COMPARISON OF SUBCUTANEOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR IMPLANTATION WITH OR WITHOUT DEFIBRILLATION TESTING: THE PRIMARY RESULTS OF THE PRAETORIAN-DFT TRIAL

LB-525395-01:皮下植入式心脏转复除颤器植入术有或无除颤测试的随机比较:PRAETORIAN-DFT试验的主要结果

2026-04-160
PRE
SPARC: a Structural Pathogenicity Algorithm for Risk Classification of hERG Variants
2025-12-250
OAAI
Catecholaminergic polymorphic ventricular tachycardia mediated by ryanodine receptor 2: a validated risk stratification

由ryanodine受体2介导的儿茶酚胺多形性室性心动过速:一项验证的风险分层

2025-12-010
PRE
Long-term outcomes of subcutaneous implantable cardioverter defibrillators: the French nationwide HONEST study

皮下植入式心律转复除颤器长期结局:法国全国性HONEST研究

2025-12-010
PRE
Impact and safety of remote monitoring of heart failure patients managed with the HeartLogic algorithm: the HeartLogic France Cohort Study

远程监测使用HeartLogic算法管理的心力衰竭患者的影响与安全性:HeartLogic法国队列研究

2025-11-010
OA
Subcutaneous implantable cardiac defibrillator in Brugada syndrome: a prospective multicentre study

皮下植入式心律转复除颤器在Brugada综合征中的应用:一项前瞻性多中心研究

2025-10-010
PRE
Phenotypic spectrum of cardiac conduction disturbance and cardiomyopathy linked to titin canonical splice-site variants

与titan经典剪接位点变异相关的心脏传导障碍和心肌病的表型谱

2025-09-011
PRE
The Clinical Significance of Atrial Fibrillation in Non–High-Risk Brugada Syndrome

非高风险Brugada综合征中心房颤动的临床意义

2025-08-270
PREAI
S-ICD Implantation Following TV-ICD

经TV-ICD后的S-ICD植入

2025-04-240
PRE
The diagnostic role of pharmacological provocation testing in cardiac electrophysiology: a clinical consensus statement of the European Heart Rhythm Association and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC, the ESC Working Group on Cardiovascular Pharmacotherapy, the Association of European Paediatric and Congenital Cardiology (AEPC), the Paediatric & Congenital Electrophysiology Society (PACES), the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS)

药物激发试验在心脏电生理学中的诊断作用:欧洲心律学会(EHRA)和欧洲经皮心血管介入协会(EAPCI)的欧洲心脏病学会(ESC)、欧洲心血管药物疗法工作组(ESC)、欧洲儿科及先天性心脏病学会(AEPC)、儿科及先天性电生理学会(PACES)、心律学会(HRS)、亚太心律学会(APHRS)和拉丁美洲心律学会(LAHRS)的临床共识声明

2025-04-010
PRE
Pain after subcutaneous implantable cardioverter-defibrillator implantation: A secondary analysis of the PRAETORIAN-DFT trial

皮下植入式心律转复除颤器植入后的疼痛:PRAETORIAN-DFT试验的二次分析

2025-03-310
OAAI
International Multicenter Cohort Study on Beta-Blocker-Free Treatment Strategies for Catecholaminergic Polymorphic Ventricular Tachycardia Patients
2025-02-010
PRE
Personalized screening before subcutaneous cardioverter-defibrillator implantation: Usefulness and outcomes in clinical practice-the S-ICD screening SIS prospective study
2024-12-010
PRE
aTrial arrhythmias in inhEriTed aRrhythmIa Syndromes: results from the TETRIS study
2024-11-111
OAAI